# Riverside Partners

Riverside Partners is a Private Equity based in Boston, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Founded:** 1989
- **Assets under management:** Undisclosed
- **Website:** www.riversidepartners.com
- **Wikidata:** Q7338574

## Regulatory record

- **CRD number:** 160754
- **SEC file number:** 801-73262
- **Registration status:** APPROVED
- **Latest Form ADV filing:** 2026-04-27T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/160754

## About

Riverside Partners is a Boston-based private equity firm founded in 1989 that helps growing middle-market technology and healthcare companies achieve their next level of success. The firm partners with companies by leveraging approximately $1B of assets, its network, experience, and other resources on behalf of institutional investors. It focuses exclusively on technology and healthcare and provides support beyond capital as former operators and consultants turned investors.

## Sectors

- Technology
- Healthcare

## People

- David Belluck — General Partner
- Steve Kaplan — General Partner
- Craig Stern — General Partner

## Questions

### Who runs investment decisions at Riverside Partners?

The three General Partners — David Belluck, Steve Kaplan, and Craig Stern — run investment decisions. Belluck has been with the firm since 1992 and chairs the investment committee. Kaplan joined in 2006 with operating experience at Harris Graphics and The Coleman Company plus a stint as a BCG partner. Stern joined in 2012 after investing in technology and media at Providence Equity Partners and General Atlantic.

### Does Riverside Partners make fund commitments or only direct investments?

Riverside invests directly — the firm does not operate as a fund of funds. It writes equity checks for control buyouts and minority growth investments, and it funds add-on acquisitions through its portfolio companies. The firm does not mention making LP commitments to outside managers.

### What EBITDA range does Riverside target?

Riverside targets companies generating $3 million to $15 million in EBITDA. The firm describes itself as focused on small- and medium-sized companies that are leaders in their niche. Add-on acquisitions can fall below that range, and the firm states it will pursue value-accretive add-ons "of any size."

### Which sectors does Riverside Partners avoid?

The firm explicitly operates in only two sectors — technology and healthcare — and does not pursue consumer, industrials, financial services, or energy investments. Within healthcare, confirmed subsectors include medical products, provider services, contract manufacturing, pharma services, lab products, and healthcare IT. Technology subsectors include software, telecommunications, information services, tech-enabled business services, and transaction processing.

### How is Riverside Partners connected to The Riverside Company?

Riverside Partners is unrelated to The Riverside Company — a global private equity firm also focused on the middle market but headquartered in New York and Cleveland. Riverside Partners has always been Boston-based and exclusively invests in technology and healthcare, while The Riverside Company operates across multiple sectors and geographies.

## Related profiles

- [Redstone Capital Corporation](https://altss.com/profile/redstone-capital-corporation)
- [Sage Capital Partners](https://altss.com/profile/sage-capital-partners)

---

Last updated: 2026-08-11T15:07:57.118Z

Canonical page: https://altss.com/profile/riverside-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology